Original Article

99 cases were operated while we could not use antibiotics. The author traced X-ray photos on paper and measured areas of the peeled cavities with a planimeter. Results were as follows. 1) 66 cases had increasing stage and the rates were more than 30 %. 2) Cases with good developments showed larger original areas (50〜100cm^2) and smaller increasing rates (less than 30 %). 3) Also their X-ray photos showed coinciding or almost coinciding lines of the apices of lungs and the bases of cavities, but we had to take precautions against suppuration when they showed a horizontal line several days after operation. 4) Most of too high degree of adhesion or thickning of pleura did not show good results. When we found a cord which we must manage with some procedures by pneumolysis we must attend to suppuration too. 5)We ought to resect 4th or 5th rib more than 20 cm and 5th or 4th several cm supplementary. 6) As a method of constriction we commend the INVAGI.NATION method. 7) The author noticed in a considerable number of cases that the areas of cavities increased again after they kept long balanced stages

Atherosclerosis V, Proceeding of the Fifth International Symposium, A.M. Gotto, L.C. Smith, B. Allen, Spring Verlag, 1979(BOOK REVIEW)

Antiviral effect of micafungin on three strains of human rhinoviruses. H1HeLa cells were infected with human rhinovirus type 14 (A), 21 (B), or 71 (C) (100 CCID50) and immediately treated with indicated concentrations of micafungin. Three days after compound treatment antiviral activity was determined by the reduction of cytopathic effect using MTT assay. Cell viability of DMSO-treated cells was set to 0 % and that of uninfected cells was set to 100 %. (TIF 100 kb

A Novel Series of Highly Potent Small Molecule Inhibitors of Rhinovirus Replication

Human rhinoviruses (hRVs) are the main causative pathogen for common colds and are associated with the exacerbation of asthma. The wide variety in hRV serotypes has complicated the development of rhinovirus replication inhibitors. In the current investigation, we developed a novel series of benzothiophene derivatives and their analogues (<b>6</b>–<b>8</b>) that potently inhibit the replication of both hRV-A and hRV-B strains. Compound <b>6g</b> inhibited the replication of hRV-B14, A21, and A71, with respective EC₅₀ values of 0.083, 0.078, and 0.015 μM. The results of a time-of-addition study against hRV-B14 and hRV-A16 and resistant mutation analysis on hRV-B14 implied that <b>6g</b> acts at the early stage of the viral replication process, interacting with viral capsid protein. A molecular docking study suggested that <b>6g</b> has a capsid-binding mode similar to that of pleconaril. Finally, derivatives of <b>6</b> also displayed significant inhibition against poliovirus 3 (PV3) replication, implying their potential inhibitory activities against other enterovirus species

Additional file 2: Figure S2. of Antiviral activity of micafungin against enterovirus 71

Micafungin inhibits the replication of CVB replicon. (A) Vero cells were transfected with in vitro transcribed CVB3 replicon RNAs, instantly treated with indicated concentrations of micafungin for 8 hours and then assayed for firefly luciferase activity. Luciferase activity of DMSO-treated cells was set to 100 %. (B) At the same condition another set of CVB3 replicon-transfected cells were assayed for cell viability by using CellTiter-Glo reagent. Activity of DMSO-treated cells was set to 100 %. (TIF 100 kb

Additional file 1: Figure S1. of Antiviral activity of micafungin against enterovirus 71

Time-dependent luciferase activity of EV71 replicon in Vero cells. Vero cells were transfected with in vitro transcribed EV71-replicon RNAs and then firefly luciferase activity was measured at an interval of two hours. (TIF 80 kb